Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06171659 · ClinicalTrials.gov registry record

FDG PET/MR Imaging of Peripheral Pain Generators

A clinical trial of Pain and Nociceptive Pain, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
128
Enrollment target
1
Study location

NCT06171659: Recruiting study of Pain and Nociceptive Pain, sponsored by University of Wisconsin, Madison.

NCT06171659 is a study of Pain and Nociceptive Pain that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 128 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06171659, a study of Pain and Nociceptive Pain, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
128 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to determine if a PET/MRI scan using FDG can accurately identify the source of chronic pain. Identifying the source of pain may help doctors treat chronic pain more effectively. Approximately 128 participants will be enrolled and can expect to be on study for up to 12 months.

Conditions Studied

Interventions

  • DEVICE PET/MRI
  • DRUG FDG radiotracer
  • DEVICE PET/CT imaging

Study Locations (1)

Wisconsin

  • UW School of Medicine and Public Health - Madison

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2024-11-19
Est. Completion 2027-06
University of Wisconsin, Madison

1,039 total trials

What NCT06171659 shows while recruiting

NCT06171659 is an observational study that tracks outcomes without assigning an intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (58% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which PET/MRI is the first listed.

NCT06171659 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06171659 about?

NCT06171659 is a clinical study titled "FDG PET/MR Imaging of Peripheral Pain Generators". The purpose of this research is to determine if a PET/MRI scan using FDG can accurately identify the source of chronic pain. Identifying the source of pain may help doctors treat chronic pain more effectively. Approximately 128 participants will be enrolled and can expect to be on study for up to 12...

What is the current status of trial NCT06171659?

This trial is currently recruiting. The enrollment target is 128 participants. The study started on 2024-11-19. Estimated completion is 2027-06.

What conditions does trial NCT06171659 study?

This clinical trial studies the following conditions: Pain, Nociceptive Pain.

What interventions are being tested in trial NCT06171659?

The interventions under investigation include: PET/MRI (DEVICE), FDG radiotracer (DRUG), PET/CT imaging (DEVICE).

Who is sponsoring clinical trial NCT06171659?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06171659 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06171659's enrollment target sits among peer trials

128 128th of 374 higher than 247 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06171659, the US trial registry maintained by the National Library of Medicine. NCT06171659 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.